227 related articles for article (PubMed ID: 17449718)
1. The activin A-follistatin system: potent regulator of human extracellular matrix mineralization.
Eijken M; Swagemakers S; Koedam M; Steenbergen C; Derkx P; Uitterlinden AG; van der Spek PJ; Visser JA; de Jong FH; Pols HA; van Leeuwen JP
FASEB J; 2007 Sep; 21(11):2949-60. PubMed ID: 17449718
[TBL] [Abstract][Full Text] [Related]
2. Follistatin restricts bone morphogenetic protein (BMP)-2 action on the differentiation of osteoblasts in fetal rat mandibular cells.
Abe Y; Abe T; Aida Y; Hara Y; Maeda K
J Bone Miner Res; 2004 Aug; 19(8):1302-7. PubMed ID: 15231018
[TBL] [Abstract][Full Text] [Related]
3. 1α,25-dihydroxyvitamin D3 stimulates activin A production to fine-tune osteoblast-induced mineralization.
Woeckel VJ; van der Eerden BC; Schreuders-Koedam M; Eijken M; Van Leeuwen JP
J Cell Physiol; 2013 Nov; 228(11):2167-74. PubMed ID: 23589129
[TBL] [Abstract][Full Text] [Related]
4. The influence of type I collagen on the development and maintenance of the osteoblast phenotype in primary and passaged rat calvarial osteoblasts: modification of expression of genes supporting cell growth, adhesion, and extracellular matrix mineralization.
Lynch MP; Stein JL; Stein GS; Lian JB
Exp Cell Res; 1995 Jan; 216(1):35-45. PubMed ID: 7813631
[TBL] [Abstract][Full Text] [Related]
5. Activin A suppresses osteoblast mineralization capacity by altering extracellular matrix (ECM) composition and impairing matrix vesicle (MV) production.
Alves RD; Eijken M; Bezstarosti K; Demmers JA; van Leeuwen JP
Mol Cell Proteomics; 2013 Oct; 12(10):2890-900. PubMed ID: 23781072
[TBL] [Abstract][Full Text] [Related]
6. Differential effect of activin A and BMP-7 on myofibroblast differentiation and the role of the Smad signaling pathway.
You L; Kruse FE
Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):72-81. PubMed ID: 11773015
[TBL] [Abstract][Full Text] [Related]
7. Cell-type-dependent up-regulation of in vitro mineralization after overexpression of the osteoblast-specific transcription factor Runx2/Cbfal.
Byers BA; Pavlath GK; Murphy TJ; Karsenty G; García AJ
J Bone Miner Res; 2002 Nov; 17(11):1931-44. PubMed ID: 12412799
[TBL] [Abstract][Full Text] [Related]
8. Possible involvement of protein kinases and Smad2 signaling pathways on osteoclast differentiation enhanced by activin A.
Murase Y; Okahashi N; Koseki T; Itoh K; Udagawa N; Hashimoto O; Sugino H; Noguchi T; Nishihara T
J Cell Physiol; 2001 Aug; 188(2):236-42. PubMed ID: 11424090
[TBL] [Abstract][Full Text] [Related]
9. Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix.
Owen TA; Aronow M; Shalhoub V; Barone LM; Wilming L; Tassinari MS; Kennedy MB; Pockwinse S; Lian JB; Stein GS
J Cell Physiol; 1990 Jun; 143(3):420-30. PubMed ID: 1694181
[TBL] [Abstract][Full Text] [Related]
10. Development of the osteoblast phenotype in primary human osteoblasts in culture: comparison with rat calvarial cells in osteoblast differentiation.
Siggelkow H; Rebenstorff K; Kurre W; Niedhart C; Engel I; Schulz H; Atkinson MJ; Hüfner M
J Cell Biochem; 1999 Oct; 75(1):22-35. PubMed ID: 10462701
[TBL] [Abstract][Full Text] [Related]
11. Bone morphogenetic protein-2 restores mineralization in glucocorticoid-inhibited MC3T3-E1 osteoblast cultures.
Luppen CA; Smith E; Spevak L; Boskey AL; Frenkel B
J Bone Miner Res; 2003 Jul; 18(7):1186-97. PubMed ID: 12854828
[TBL] [Abstract][Full Text] [Related]
12. Acidosis inhibits bone formation by osteoblasts in vitro by preventing mineralization.
Brandao-Burch A; Utting JC; Orriss IR; Arnett TR
Calcif Tissue Int; 2005 Sep; 77(3):167-74. PubMed ID: 16075362
[TBL] [Abstract][Full Text] [Related]
13. Four and half lim protein 2 (FHL2) stimulates osteoblast differentiation.
Lai CF; Bai S; Uthgenannt BA; Halstead LR; McLoughlin P; Schafer BW; Chu PH; Chen J; Otey CA; Cao X; Cheng SL
J Bone Miner Res; 2006 Jan; 21(1):17-28. PubMed ID: 16355270
[TBL] [Abstract][Full Text] [Related]
14. Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: an in vitro model of osteoblast development.
Quarles LD; Yohay DA; Lever LW; Caton R; Wenstrup RJ
J Bone Miner Res; 1992 Jun; 7(6):683-92. PubMed ID: 1414487
[TBL] [Abstract][Full Text] [Related]
15. Enhanced expression of the inorganic phosphate transporter Pit-1 is involved in BMP-2-induced matrix mineralization in osteoblast-like cells.
Suzuki A; Ghayor C; Guicheux J; Magne D; Quillard S; Kakita A; Ono Y; Miura Y; Oiso Y; Itoh M; Caverzasio J
J Bone Miner Res; 2006 May; 21(5):674-83. PubMed ID: 16734382
[TBL] [Abstract][Full Text] [Related]
16. Changes in extracellular activin A:follistatin ratio during differentiation of a mesenchymal progenitor cell line, ROB-C26 into osteoblasts and adipocytes.
Kawabata N; Kamiya N; Suzuki N; Matsumoto M; Takagi M
Life Sci; 2007 Jun; 81(1):8-18. PubMed ID: 17512555
[TBL] [Abstract][Full Text] [Related]
17. Sortilin is upregulated during osteoblastic differentiation of mesenchymal stem cells and promotes extracellular matrix mineralization.
Maeda S; Nobukuni T; Shimo-Onoda K; Hayashi K; Yone K; Komiya S; Inoue I
J Cell Physiol; 2002 Oct; 193(1):73-9. PubMed ID: 12209882
[TBL] [Abstract][Full Text] [Related]
18. The activin-follistatin system and in vitro early follicle development in goats.
Silva JR; Tharasanit T; Taverne MA; van der Weijden GC; Santos RR; Figueiredo JR; van den Hurk R
J Endocrinol; 2006 Apr; 189(1):113-25. PubMed ID: 16614386
[TBL] [Abstract][Full Text] [Related]
19. Follistatin rescues the inhibitory effect of activin A on the differentiation of bovine preadipocyte.
Hirai S; Matsumoto H; Moriya NH; Kawachi H; Yano H
Domest Anim Endocrinol; 2007 Oct; 33(3):269-80. PubMed ID: 16829013
[TBL] [Abstract][Full Text] [Related]
20. Cell viability, osteoblast differentiation, and gene expression are altered in human osteoblasts from hypertrophic fracture non-unions.
Hofmann A; Ritz U; Hessmann MH; Schmid C; Tresch A; Rompe JD; Meurer A; Rommens PM
Bone; 2008 May; 42(5):894-906. PubMed ID: 18314404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
